JHIU
GNMK

Janus Henderson Investors US’s GenMark Diagnostics, Inc GNMK Stock Holding History

Janus Henderson Investors US’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-744,887
Closed -$6.68M – 1143
2014
Q3 		$6.68M Buy
744,887
+41,213
+6% +$443K 0.01% 746
2014
Q2 		$9.52M Buy
703,674
+53,088
+8% +$554K 0.01% 692
2014
Q1 		$6.47M Buy
650,586
+223,947
+52% +$2.78M 0.01% 737
2013
Q4 		$5.68M Sell
426,639
-5,193
-1% -$63.1K 0.01% 756
2013
Q3 		$5.25M Buy
+431,832
New +$4.63M 0.01% 742

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Investors US's GNMK Position: Q4 2014 in Review

Janus Henderson Investors US sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2014, closing a stake of 744,887 shares — an estimated $6.68M sold.

Janus Henderson Investors US first reported a position in GNMK in Q3 2013 and held it in 5 quarters. The position peaked at $9.52M in Q2 2014. 79 funds tracked by Wall St. Rank hold GNMK as of Q4 2014.

  • Janus Henderson Investors US reported no remaining GenMark Diagnostics, Inc position as of Q4 2014 after selling out during the quarter.
  • Janus Henderson Investors US sold 744,887 GenMark Diagnostics, Inc shares in Q4 2014, an estimated $6.68M.
  • Janus Henderson Investors US first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 5 quarters.
  • Janus Henderson Investors US's GenMark Diagnostics, Inc position peaked at $9.52M in Q2 2014.
  • 79 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2014.

Based on Janus Henderson Investors US's 13F filing for Q4 2014, filed 18 Feb 2015.